IL6 and systemic-onset juvenile idiopathic arthritis: STAT3 is activated by several pro-inflammatory cytokines, including interleukin-6 (IL-6)24–26, which is a prime target for therapeutic intervention in several inflammatory diseases including rheumatoid arthritis, Still’s disease and giant cell arthritis.